Aug 5, 2026 04:45PM
Aug 5, 2026 04:01PM
May 5, 2026 07:00AM
Mar 9, 2026 04:22PM
Mar 9, 2026 07:04AM
Mar 9, 2026 07:00AM
Nov 10, 2025 07:33AM Editas Medicine (EDIT) Tops Q3 EPS by 2c
Nov 10, 2025 07:00AM
Aug 13, 2025 05:58AM
Aug 12, 2025 05:45PM
Aug 12, 2025 04:01PM
May 13, 2025 07:26AM
May 12, 2025 04:30PM
May 5, 2025 04:01PM Editas Medicine to Announce First Quarter 2025 Financial Results and to Participate in Investor Conference in May
Mar 5, 2025 04:52PM
Mar 5, 2025 04:05PM
Feb 24, 2025 09:00AM
Nov 5, 2024 04:19PM
Nov 4, 2024 07:45AM
Nov 4, 2024 07:30AM
Oct 22, 2024 07:02AM Editas Medicine (EDIT) Announces Progress Towards 2024 Goals, Including Achievement of In Vivo Preclinical Proof of Concept and Strategic Update
Oct 22, 2024 07:00AM
Aug 7, 2024 07:03AM
Aug 7, 2024 07:00AM
Jul 31, 2024 07:00AM
May 8, 2024 07:06AM
May 8, 2024 07:00AM
May 2, 2024 07:00AM Editas Medicine Announces First Quarter 2024 Results Conference Call and Upcoming Investor Events
Feb 28, 2024 07:03AM
Feb 28, 2024 07:00AM
Feb 21, 2024 07:00AM
Nov 3, 2023 07:00AM
Oct 27, 2023 07:00AM
Aug 2, 2023 07:08AM
Aug 2, 2023 07:00AM Editas Medicine Announces Second Quarter 2023 Results and Business Updates
Jul 26, 2023 07:00AM
May 5, 2023 07:53AM
May 5, 2023 07:00AM
May 1, 2023 06:45AM
May 1, 2023 06:45AM
Feb 22, 2023 06:16AM
Feb 22, 2023 06:15AM Editas Medicine Announces Fourth Quarter and Full Year 2022 Results and Business Updates
Feb 22, 2023 06:15AM
Feb 15, 2023 06:45AM
Feb 15, 2023 06:45AM
Nov 2, 2022 06:30AM
Nov 2, 2022 06:30AM
Oct 26, 2022 06:30AM
Oct 26, 2022 06:30AM Editas Medicine to Host Conference Call Discussing Third Quarter 2022 Results and Corporate Update
Aug 3, 2022 06:43AM

1,216,467 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All